DekaBank Deutsche Girozentrale’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,092	Closed	-$61K	–	1546
2023 Q3	$61K	Buy	+9,092	New	+$75.6K	﹤0.01%	1372

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

DekaBank Deutsche Girozentrale's PNT Position: Q4 2023 in Review

DekaBank Deutsche Girozentrale sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 9,092 shares — an estimated $61K sold.

DekaBank Deutsche Girozentrale first reported a position in PNT in Q3 2023 and held it in 1 quarter. The position peaked at $61K in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

DekaBank Deutsche Girozentrale reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 9,092 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $61K.
DekaBank Deutsche Girozentrale first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2023 and held it in 1 quarter.
DekaBank Deutsche Girozentrale's POINT Biopharma Global Inc. Common Stock position peaked at $61K in Q3 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2023, filed 24 Jan 2024.